Sen. Tammy Baldwin (D-Wis.) has introduced legislation to revoke China’s Permanent Normal Trade Relations (PNTR) status, renewing a congressional effort to withdraw preferential tariff treatment granted to Beijing more than two decades ago. The proposal follows similar Republican legislation introduced in 2024 and reflects longstanding concerns in Congress over Chinese trade practices, industrial subsidies and their effects on U.S. manufacturing.
The Ending China’s Special Treatment Act would revoke China’s PNTR status one year after enactment, subjecting Chinese imports to the generally higher tariff rates established under Column 2 of the Harmonized Tariff Schedule (HTS), rather than the Column 1 rates applicable to countries receiving normal trade relations treatment.
The legislation would also direct the U.S. Trade Representative, in consultation with the U.S. International Trade Commission, the U.S.-China Economic and Security Review Commission and the Commerce Department, to prepare a report informing future policy decisions concerning the bilateral economic relationship.
“We need a trade system that puts American workers, companies, and families first. Unfortunately, for over two decades, we've rolled out the red carpet for China while they've cheated the system and left American workers paying the price,” Baldwin said in announcing the legislation.
Baldwin also criticized President Trump's trade policies, arguing that shifting tariffs have increased costs without restoring American manufacturing employment. She called for a fundamental reassessment of U.S. trade relations with China.
The proposal revives a legislative initiative advanced by Republicans in 2024. In September of that year, Sens. Tom Cotton (R-Ark.), Marco Rubio (R-Fla.) and Josh Hawley (R-Mo.) introduced the Neither Permanent Nor Normal Trade Relations Act, which proposed terminating China's PNTR status, phasing in higher tariffs over five years and imposing duties of 100% on certain national-security-sensitive products.
Rubio, then a Florida senator, characterized China's preferential treatment as a major policy failure.
“Giving Communist China the same trade benefits that we give to our greatest allies was one of the most catastrophic decisions that our country has ever made. Our country’s trade deficit with China more than quadrupled, and we exported millions of American jobs. Ending normal trade relations with China is a no-brainer,” Rubio said.
The 2024 Senate proposal also would have authorized additional import quotas and restrictions, eliminated de minimis treatment for covered countries and directed tariff revenue toward affected farmers and manufacturers, defense procurement and debt reduction.
Rep. John Moolenaar (R-Mich.), chairman of the House Select Committee on the Chinese Communist Party, separately advanced legislation in 2024 to revoke China's PNTR status and establish a China-specific tariff schedule.
The U.S.-China Economic and Security Review Commission subsequently recommended repealing China's PNTR status in its 2024 annual report to Congress, citing structural changes in China's economy and the limitations of existing U.S. trade remedies.
Revocation would represent a substantial change in the statutory foundation of U.S.-China trade relations. Congress granted China PNTR status through legislation enacted in 2000, before China's accession to the World Trade Organization in December 2001. Ending that treatment would increase tariffs across a broad range of Chinese products, with implications for importers, manufacturers, supply chains and U.S. consumers.
The legislative effort continued in 2025, when Cotton reintroduced the proposal with Sens. Jim Banks (R-Ind.) and Hawley, while Moolenaar joined Rep. Tom Suozzi (D-N.Y.) in introducing a bipartisan House version.
Baldwin's measure differs from the earlier proposals by providing a one-year transition to existing Column 2 rates rather than creating a separate, phased tariff structure for China. It also arrives as Congress considers the economic consequences of revocation.
The International Trade Commission opened an investigation in February 2026 examining the effects on U.S. industries, consumers and product sourcing.
Comments
No comments on this item Please log in to comment by clicking here